Name
Perearst HEPP NIGOL OÜ
Registry code
10946296
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.09.2003 (21)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
297 024 €
13 416 €
5%
2 695 €
(estimate is approximate)
40 183 €
4
Submitted
No tax arrears
33%
14%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Hepp Nigol 29.08.1968 (56) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 31.10.2020 | 2020 28.06.2021 | 2021 28.06.2022 | 2022 29.06.2023 | 2023 27.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 190 774 € | 210 926 € | 241 038 € | 259 351 € | 297 024 € |
| Net profit (loss) for the period | 10 343 € | 3 718 € | 580 € | 22 495 € | 13 416 € |
| Profit Margin | 5% | 2% | 0% | 9% | 5% |
| Current Assets | 73 723 € | 96 497 € | 76 226 € | 71 318 € | 84 006 € |
| Fixed Assets | 4 097 € | 7 100 € | 4 748 € | 11 149 € | 9 797 € |
| Total Assets | 77 820 € | 103 597 € | 80 974 € | 82 467 € | 93 803 € |
| Current Liabilities | 7 846 € | 49 905 € | 46 702 € | 40 700 € | 53 620 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 69 974 € | 53 692 € | 34 272 € | 41 767 € | 40 183 € |
| Employees | 4 | 4 | 4 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 24 074.46 € | 25 506.66 € | 6 |
| 2023 Q4 | - | 19 877.79 € | 19 902.46 € | 6 |
| 2023 Q3 | - | 16 584.28 € | 17 400.23 € | 5 |
| 2023 Q2 | - | 16 734.4 € | 17 589.97 € | 5 |
| 2023 Q1 | - | 14 623.64 € | 14 556.39 € | 6 |
| 2022 Q4 | - | 14 997 € | 13 887.28 € | 5 |
| 2022 Q3 | - | 12 815.91 € | 12 394.85 € | 5 |
| 2022 Q2 | - | 15 309.13 € | 15 575.82 € | 6 |
| 2022 Q1 | - | 15 005.48 € | 15 244.62 € | 7 |
| 2021 Q4 | - | 12 031.83 € | 12 582.07 € | 5 |
| 2021 Q3 | - | 14 333.85 € | 13 305.38 € | 5 |
| 2021 Q2 | - | 15 817.96 € | 14 648.16 € | 5 |
| 2021 Q1 | - | 15 667.06 € | 15 700.88 € | 6 |
| 2020 Q4 | - | 11 054.96 € | 11 797.72 € | 6 |
| 2020 Q3 | - | 11 243.17 € | 12 001.76 € | 5 |
| 2020 Q2 | - | 9 792.31 € | 10 429.32 € | 5 |
| 2020 Q1 | - | 9 579.7 € | 10 199.3 € | 5 |
